Objectives To determine the costs directly or indirectly related to bronchopulmonary
dysplasia (BPD) in preterm infants. The secondary objective was to stratify the costs based …

Objective To evaluate the healthcare costs attributed to major morbidities associated with
prematurity, namely, bronchopulmonary dysplasia (BPD), intraventricular hemorrhage …

Bronchopulmonary dysplasia (BPD) is the most common complication of prematurity
involving both pre-and post-natal factors. A large, prospective, longitudinal cohort study was …

Background Bronchopulmonary dysplasia (BPD), a common morbidity among very preterm
infants, is associated with chronic disease and neurodevelopmental impairments. A …

Introduction: Vascular remodeling and compromised alveolar development are hallmarks of
chronic pulmonary diseases such as bronchopulmonary dysplasia (BPD). Despite advances …

Aim To develop a fast bedside test for prediction and early targeted intervention of
bronchopulmonary dysplasia (BPD) to improve the outcome. Methods In a multicentre study …

Background Bronchopulmonary dysplasia (BPD) is a chronic lung disease in premature
infants that may cause long-term lung dysfunction. Accumulating evidence supports the …

Introduction Approximately 5% of global preterm births are extremely premature (EP),
defined as occurring at less than 28 weeks gestational age. Advances in care have led to an …

Background and Objective: As bronchopulmonary dysplasia (BPD) can lead to considerable
mortality and morbidity, this disease is the focus of attention in neonatology. Vitamin D (VD) …

Objectives To report the current incidence of bronchopulmonary dysplasia (BPD) and to
compare changes in weight and head circumference between infants who developed BPD …